ClearanceBrief
Recall Z-0578-2026 ยท PQP Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System

Foundation Medicine, Inc.

FoundationOne Liquid CDx (F1LCDx), TECH-0009 version 6.0

DateNov 21, 2025 (initiated Nov 8, 2022)
StatusOpen, Classified
ReasonReports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.
Root causeUnder Investigation by firm
ActionOn 08 November 2022, Notification Emails with amended reports were emailed to customers. The Foundation Medicine's Medical Affairs team email alerted its customer to a recently issued amended report [Date of Amended Report] for one of your patients [Patient Order Number]. This Amended Report has been issued to update the report template to include the correct [FoundationOneLiquid CDx/FoundationOneCDx] reporting template, including the associated Claims page. Please note that other aspects of this report may have changed from the previous version to reflect the most up-to-date reporting infor
Quantity18 units (17 US, 1 OUS)
DistributionUS Nationwide distribution to states of: AL, AZ, CA, FL, GA, IL, IN, KS, KY, ME, MN, MO, MS, MT, NC, NJ, NV, NY, OK, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV. OUS International to countries: Japan, Singapore.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.